FlexFactory is a centrally automation integrated, flexible biomanufacturing platform.
Dr Reddy's Laboratories, the second largest drug maker in India by sales, on Wednesday offered to buyback around 44.85 lakh shares for up to Rs 1,569.4 crore.
Hyderabad: City-based Dr Reddy’s Laboratories will install a FlexFactory, a single-use manufacturing platform, to expand biologics production capacity at its facility, said GE Healthcare in a statement.
FlexFactory will make Dr Reddy’s biopharmaceutical manufacturing set-up more flexible and efficient strengthening the company’s position in the global biosimilars market, it said.
FlexFactory is a centrally automation integrated, flexible biomanufacturing platform. It allows manufacturers to seamlessly establish biopharmaceutical manufacturing capacity within an existing building.
( Source : Deccan Chronicle. )
Next Story